These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 10601851)
41. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. McKee MD; Nanci A; Khan SR J Bone Miner Res; 1995 Dec; 10(12):1913-29. PubMed ID: 8619372 [TBL] [Abstract][Full Text] [Related]
42. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis. Yagisawa T; Ito F; Osaka Y; Amano H; Kobayashi C; Toma H J Urol; 2001 Sep; 166(3):1078-82. PubMed ID: 11490302 [TBL] [Abstract][Full Text] [Related]
43. The effect of preincubation of seed crystals of uric acid and monosodium urate with undiluted human urine to induce precipitation of calcium oxalate in vitro : implications for urinary stone formation. Grover PK; Ryall RL Mol Med; 2002 Sep; 8(9):525-35. PubMed ID: 12456991 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of growth and aggregation of calcium oxalate crystals in vitro--a comparison of four human proteins. Grover PK; Moritz RL; Simpson RJ; Ryall RL Eur J Biochem; 1998 May; 253(3):637-44. PubMed ID: 9654060 [TBL] [Abstract][Full Text] [Related]
45. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis. Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338 [TBL] [Abstract][Full Text] [Related]
46. Simple, sensitive and accurate method for the quantification of prothrombin mRNA by using competitive PCR. Grover PK; Stapleton AM; Miyazawa K; Ryall RL Biochem J; 2001 May; 356(Pt 1):111-20. PubMed ID: 11336642 [TBL] [Abstract][Full Text] [Related]
47. Quantification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in vitro in the urine of healthy controls and stone-forming patients. Atmani F; Khan SR Urol Int; 2002; 68(1):54-9. PubMed ID: 11803269 [TBL] [Abstract][Full Text] [Related]
48. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477 [TBL] [Abstract][Full Text] [Related]
49. Effects of allopurinol on renal stone formation and osteopontin expression in a rat urolithiasis model. Yasui T; Sato M; Fujita K; Ito Y; Nomura S; Kohri K Nephron; 2001 Feb; 87(2):170-6. PubMed ID: 11244313 [TBL] [Abstract][Full Text] [Related]
50. Deposition of calcium phosphate and calcium oxalate crystals in the kidneys. Khan SR; Glenton PA J Urol; 1995 Mar; 153(3 Pt 1):811-7. PubMed ID: 7861545 [TBL] [Abstract][Full Text] [Related]
51. Crystal matrix protein is related to human prothrombin. Stapleton AM; Simpson RJ; Ryall RL Biochem Biophys Res Commun; 1993 Sep; 195(3):1199-203. PubMed ID: 8216249 [TBL] [Abstract][Full Text] [Related]
52. Potential therapeutic activity of Phlogacanthus thyrsiformis Hardow (Mabb) flower extract and its biofabricated silver nanoparticles against chemically induced urolithiasis in male Wistar rats. Das P; Kumar K; Nambiraj A; Rajan R; Awasthi R; Dua K; M H Int J Biol Macromol; 2017 Oct; 103():621-629. PubMed ID: 28528955 [TBL] [Abstract][Full Text] [Related]
53. The biochemical and histopathological investigation of amlodipine in ethylene glycol-induced urolithiasis rat model. Albayrak A; Bayir Y; Halici Z; Karakus E; Oral A; Keles MS; Colak S; Zipak T; Dorman E; Uludag K; Yayla N; Gulcan E Ren Fail; 2013; 35(1):126-31. PubMed ID: 23252427 [TBL] [Abstract][Full Text] [Related]
54. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Khan SR; Hackett RL Scan Electron Microsc; 1985; (Pt 2):759-74. PubMed ID: 3901237 [TBL] [Abstract][Full Text] [Related]